showed the raloxifene inhibitory effect on the RT4 cell growth via enhancement of BTG2 expression, suggesting BTG2 may play as a tumor suppressor gene in the bladder cancer 13. The gene discussed is BTG2; the disease is urinary bladder carcinoma.